Insider: ROTE WILLIAM E. Chief Research Officer - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 109,087 | 0 | 109,087 |
| Value | $3,320,608.28 | $0.00 | $3,320,608.28 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/03/2026 | DDS | 12,446 | Direct | COM | $32.87 | $409,100.02 | 109,087 |
| 12/24/2025 | DDS | 60,000 | Direct | COM | $40.10 | $2,406,180.00 | 101,443 |
| 05/05/2025 | DDS | 3,198 | Direct | COM | $21.05 | $67,317.90 | 100,241 |
| 02/12/2025 | DDS | 5,200 | Direct | COM | $23.53 | $122,356.00 | 98,519 |
| 02/03/2025 | DDS | 8,951 | Direct | COM | $19.78 | $177,050.78 | 95,719 |
| 01/22/2025 | DDS | 2,437 | Direct | COM | $19.46 | $47,424.02 | 83,170 |
| 09/09/2024 | DDS | 4,387 | Direct | COM | $11.52 | $50,538.24 | 84,455 |
| 02/01/2024 | DDS | 2,174 | Direct | COM | $8.53 | $18,547.70 | 83,310 |
| 02/01/2024 | DDS | 2,590 | Direct | COM | $8.86 | $22,947.40 | 80,720 |
| 01/23/2024 | DDS | 2,062 | Direct | COM | $8.96 | $18,475.52 | 60,484 |
| 09/05/2023 | DDS | 1,815 | Direct | COM | $14.71 | $26,698.65 | 61,173 |
| 05/10/2023 | DDS | 825 | Direct | COM | $16.59 | $13,686.75 | 59,211 |
| 02/01/2023 | DDS | 2,590 | Direct | COM | $22.25 | $57,627.50 | 60,036 |
| 01/24/2023 | DDS | 2,062 | Direct | COM | $21.50 | $44,333.00 | 42,376 |
| 05/11/2022 | DDS | 750 | Direct | COM | $21.93 | $16,447.50 | 44,485 |
| 05/11/2022 | DDS | 813 | Direct | COM | $21.52 | $17,492.75 | 43,672 |
| 01/31/2022 | DDS | 1,125 | Direct | COM | $27.40 | $30,825.00 | 45,235 |
| 01/24/2022 | DDS | 1,875 | Direct | COM | $24.98 | $46,837.50 | 36,520 |
| 01/11/2022 | DDS | 2,500 | Direct | COM | $27.40 | $68,500.00 | 38,395 |
| 08/17/2021 | DDS | 1,407 | Direct | COM | $17.12 | $24,085.45 | 35,731 |
| 05/12/2021 | DDS | 1,562 | Direct | COM | $19.46 | $30,396.52 | 31,707 |
| 05/11/2021 | DDS | 1,563 | Direct | COM | $19.14 | $29,915.82 | 33,269 |
| 02/18/2021 | DDS | 1,250 | Direct | COM | $28.67 | $35,837.50 | 34,832 |
| 02/17/2021 | DDS | 1,250 | Direct | COM | $27.35 | $34,187.50 | 36,082 |
| 02/08/2021 | DDS | 2,250 | Direct | COM | $31.58 | $71,055.00 | 37,332 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research